Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

172 results about "Gradient centrifugation" patented technology

Preparation method of allogenic mesenchymal stem cells by CRISPR (clustered regularly interspaced short palindromic repeats) technique editing and IGF (insulin-like growth factor) optimization and application of allogenic mesenchymal stem cells in treating myocardial infarction

ActiveCN105985985AImprove anti-apoptotic abilityPromote homingUnknown materialsFermentationAntigenInflammatory factors
The invention belongs to the field of allogenic mesenchymal stem cells, and particularly relates to a preparation method of allogenic mesenchymal stem cells by CRISPR (clustered regularly interspaced short palindromic repeats) technique editing and IGF (insulin-like growth factor) optimization and application of the allogenic mesenchymal stem cells in treating myocardial infarction. The preparation method comprises the following steps: carrying out separation by density gradient centrifugation to obtain allogenic single karyocytes, and carrying out adherent culture to obtain mesenchymal stem cells; designing a mesenchymal stem cell surface antigen B2M-gRNA and an inflammatory factor TNF-alpha-gRNA; establishing recombinant slow virus particles, and transfecting the mesenchymal stem cells; optimizing the mesenchymal stem cells by using IGF-1; and preparing drugs for treating myocardial infarctions by using the modified and optimized mesenchymal stem cells. The CRISPR/Cas9 technique is utilized to remove the antigens capable of causing immunological rejection and the inflammatory factors capable of causing inflammatory reaction on the mesenchymal stem cell surface, and the IGF-1 is utilized to enhance the apoptosis resistance of the mesenchymal stem cells and promote the homing of the mesenchymal stem cells, thereby providing a new technical scheme for preparing drugs for treating cardiovascular diseases in clinic. The prepared allogenic mesenchymal stem cells can not cause immunological rejection after cell transplantation.
Owner:SUZHOU UNIV

O type foot-and-mouth disease 146S antigen quantitative ELISA detection kit and method for using same

ActiveCN103076451ASolve efficiency problemsSolving the power test substitution problemMaterial analysisDiseaseVaccine Potency
The invention discloses an O type foot-and-mouth disease 146S antigen quantitative ELISA (enzyme-linked immuno sorbent assay) detection kit and a method for using the same. The kit comprises an ELISA plate, an O type foot-and-mouth disease standard reference antigen, a demulsifier, an O type foot-and-mouth disease rabbit antiserum, an O type foot-and-mouth disease guinea pig antiserum, a rabbit anti-guinea pig-horse radish peroxidase conjugate, a guinea pig antiserum dilute solution, a 25-fold PBST (phosphate buffer solution tween) concentrated solution, a carbonate buffer solution capsule, a citric acid-phosphate buffer solution tablet, an OPD (o-phenylenediamine) tablet, a stop solution, a plate sealing membrane, a moving liquid tank and a 96-mesh U-shaped dilution plate. The kit is an organic combination of a sucrose density gradient centrifugation method and an indirect sandwich ELISA method, integrates the advantages of the sucrose density gradient centrifugation method and the indirect sandwich ELISA method, is simple to operate and good in stability, is suitable for batch detection, can be used for distinguishing serum types, and is an ideal substitution method for antigen quantitative and vaccine efficacy detection.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Preparation method of small-size transition metal chalcogenide two-dimensional nanosheet

The invention relates to a preparation method of a small-size transition metal chalcogenide two-dimensional nanosheet. The method is characterized in that the powder of a block is treated as a raw material; a polymer is used as an additive, and polymer assistant ball milling is performed to obtain transition metal chalcogenide two-dimensional nanosheets with different sizes and different components. The method comprises three steps of weighing high polymers and polymer assistant ball milling prepared blocky powder; performing ball milling, separating, water adding, uniformly mixing and movingout; performing gradient centrifugation to obtain products with different sizes; purifying to remove excessive polymers. With the adoption of the method, the problems such as low yield, non-uniform appearance and complex processes of a current preparation method of a current small-size transition metal chalcogenide two-dimensional nanosheet can be solved; the method has the advantages of being high in yield, simple in processes, high in generality, easy to control processes,and the like; the prepared small-size transition metal chalcogenide two-dimensional nanosheet can be applied to differentfields, such as the fields of catalyzing, photoelectric and biomedicines.
Owner:NANJING UNIV OF POSTS & TELECOMM

Method for separating nano-particles at water-phase density gradient centrifugation rate

The invention relates to a method for separating nano-particles at a water-phase density gradient centrifugation rate, which mainly comprises the following steps: 1) preparing the nano-particles into a homogeneous transparent colloid nano-particle solution by means of ultrasound, stirring and the like; 2) preparing density gradient solutions with different mass percentage concentrations respectively; 3) adding certain amount of density gradient medium solutions with different concentrations into a centrifuge tube in turn to prepare a step-like or linear density gradient solution; and 4) adding the solution containing colloid nano-particles to the liquid surface of the density gradient solution slowly, and performing centrifugalization under certain condition. Because the colloid nano-particles with different sizes have different sedimentation rates in the density gradient solution and can be detained at different positions in the density gradient solution so as to achieve the effect of separation. The method has the advantages of simple method, quick separation, low cost, small influence on the stability and the purity of a sample, and the separation effect of certain section can be enhanced selectively by adjusting and controlling centrifugal parameters.
Owner:BEIJING UNIV OF CHEM TECH

Liquid-based cell smear manufacturing and dyeing machine utilizing principles of injection and pipetting

The invention relates to a liquid-based cell smear manufacturing and dyeing machine utilizing principles of injection and pipetting, which is characterized by structurally comprising a machine base, a machine body, a worktable, a horizontal slide rail, a moving arm, a horizontal motor moving device, an up-down motor moving device and a microcomputer motion control system, wherein four groups of smear manufacturing and dyeing units and a kit are mounted on the worktable board; and 24 samples can be automatically manufactured into smears and dyed when the machine runs once. The liquid-based cell smear manufacturing and dyeing machine does not need a tedious specific gravity liquid gradient centrifugation step, a micropipe type liquid drawing system of a liquid-based cytology test (LCT) machine, or processes of vacuum negative pressure drawing and positive pressure cell transfer of a microporous filter membrane of a Thinprep cytology test (TCT) machine. Cell samples are drawn, evenly mixed and scattered by using a pipetting injector and sample reagents are transferred by utilizing an accurate quantitative liquid drawing and injecting function of the pipetting injector. Cells in a settling and smear-manufacturing bin are naturally settled on a sticky glass slide by relying on the gravity of the cells and then automatically dyed. The liquid-based cell smear manufacturing and dyeing machine has the advantages that the operation is simple, the cost is relatively low, and high quality liquid-based cytological smears can be rapidly manufactured.
Owner:CHANGSHA COMBINE MEDICAL TECH

Resin ball capable of preferential adsorption of aromatic hydrocarbon component of hydrocarbon mixture, and preparation method thereof

The invention belongs to the technical field of adsorption and separation, and specifically, relates to a resin ball capable of preferential adsorption of an aromatic hydrocarbon component of a hydrocarbon mixture, and a preparation method thereof. The resin ball is a styrene resin ball which has a certain crosslinking degree and is subjected to copolymerization modification by polar monomers. Through the difference of swelling adsorption capacities of the resin ball on aromatic hydrocarbons and non-aromatic hydrocarbons, an aromatic hydrocarbon component of a hydrocarbon mixture can be adsorbed conveniently by the resin ball so that an aromatic hydrocarbon component separation effect is realized. The resin ball is a random copolymer, wherein styrene is utilized as a main monomer, and various polar monomers and different cross-linking agents are utilized to modify styrene. The resin ball is prepared from easily available raw materials, is easy for synthesis, can be recycled, is convenient for operation and aftertreatment, simplifies a process flow, and reduces an operation cost and energy consumption. In application, through a gradient centrifugation method, the resin ball provides a novel and simple approach for high-efficiency separation of aromatic hydrocarbons and non-aromatic hydrocarbons.
Owner:JILIN UNIV

Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman

InactiveCN105063181AEfficient and specific captureMicrobiological testing/measurementDiseaseRed blood cell
The invention discloses a method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of a pregnant woman. The method comprises the following steps: 1, preprocessing fresh pregnant woman maternal peripheral blood: separating and enriching monocytes containing fetal nucleated red blood cells from maternal peripheral whole blood through a density gradient centrifugation technology; 2, capturing cells: adding a separated monocyte suspension to a substrate chip modified with an antibody, and carrying out standing capturing; and 3, identifying the sex of a fetus: identifying whether the nucleated red blood cells of the captured fetus contain Y chromosome or not by using an FISH probe technology (CSP-X / Y). The method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of the pregnant woman can realize capture and identification of the fetal nucleated red blood cells from the maternal peripheral circulating blood, and allows the FISH analysis to be directly carried out in order to realize noninvasive antenatal diagnosis of the sex or 21-Trisomy syndrome and other chromosome diseases of the fetus.
Owner:石莹

Method for preparing seasonal influenza virus split vaccine

The invention provides a method for preparing a seasonal influenza virus split vaccine and a vaccine prepared by using the method, belonging to the technical field of vaccine preparation processes. The preparation method comprises the following steps of: preparing an original liquid from influenza A1, A3 and B virus strain verified as WHO (World Health Organization) recommended virus strain or similar strain through the procedures of working seed bank creation through subculture, chick embryo inoculation, virus liquid culture and harvesting, virus inactivation, ultrafilter concentration, gradient centrifugation, ultrafilter sugar removal, column chromatography, virus splitting, secondary purification and filtration sterilization; and carrying out semi-finished product configuration and finished product packaging to obtain the seasonal influenza virus split vaccine. Because gradient centrifugation purification and molecular sieve chromatography column purification are combined and secondary purification including gradient centrifugation purification after virus splitting is carried out, the method provided by the invention has the advantages of good concentration efficiency and recovery rate, low cost, high efficiency and easiness for operation. The finally prepared product has low impurity content and high HA content, and the standards of endotoxin and ovalbumin are far better than the requirements of Chinese Pharmacopoeia 2010 and European Pharmacopoeia. Moreover, the product provided by the invention does not contain thiomersal, inoculation is safer, and inoculated population is larger.
Owner:CHENGDU KANGHUA BIOLOGICAL PROD

Pig circovirus III-type virus-like particle and preparation method thereof

An embodiment of the invention discloses a pig circovirus III-type virus-like particle. A preparation method of the virus-like particle includes the steps: amplifying pig circovirus III-type Cap protein genes; constructing recombinant shuttle-plasmid pFB-Cap by the aid of the genes; constructing rB-Cap recombinant rod granules by the aid of the recombinant shuttle-plasmid pFB-Cap; transfecting therB-Cap recombinant rod granules into SF9 cells to obtain recombinant baculovirus rBV-PCV3 Cap expressing pig circovirus III-type Cap genes; enabling the recombinant baculovirus rBV-PCV3 Cap to infectHigh Five cells, and purifying the recombinant baculovirus rBV-PCV3 Cap infected by the High Five cells to obtain the pig circovirus III-type virus-like particl PCV3 VLP. A nucleotide sequence of theCap protein gene is as shown in SEQ ID NO.1. According to the particle, based on a baculovirus-insect cell expression system, preparation is implemented by the aid of High Five cell expression of serum-free suspension culture, and the PCV3 virus-like particle is acquired by combining sucrose cushion ultracentrifugation and sucrose density gradient centrifugation purification. The virus-like particle is good in immunogenicity and high in safety and has good development and application prospects.
Owner:ACAD OF MILITARY SCI PLA CHINA ACAD OF MILITARY MEDICAL SCI INST OF MILITARY VETERINARY MEDICINE

Leukocyte extract and preparation method and application thereof

The invention discloses a preparation method of leukocyte extract. Neonate cord blood is used directly as a raw material subjected to human lymphocyte separation density-gradient centrifugation to obtain PBMCs (peripheral blood mononuclear cells); amplification culture is performed via cord serum separated from the cord blood; centrifugal separating is performed to obtain supernate; leukocyte extract is acquired by ultra-filtration. The preparation method has no need for bovine serum, no heterogeneous animal proteins or stimulating factors are involved, and safety of application in human bodies is good. The leukocyte extract prepared via the method has rich natural human cellular factors, wherein bFGF (basic fibroblast growth factor) reaches 60 pg/ml and above, the yield is high, and the production cost is low. The invention also provides application of the leukocyte extract in the activation and restoration of cells. The leukocyte extract may be added to cosmetics to provide synergy with other components in cosmetic formulations; the leukocyte extract can cooperate to improve cell mitochondrial functionality, complete nutrients for cell metabolism are provided, and the cell activating function of the leukocyte extract is significantly improved.
Owner:上海蕙禾生物科技事务所

Umbilical cord blood mesenchymal stem cell separation liquid and separation flow

The invention discloses umbilical cord blood mesenchymal stem cell separation liquid and an umbilical cord blood mesenchymal stem cell separation flow. The separation liquid is prepared by mixing saccharosan of which the concentration is 9 percent and meglumine diatrizoate of which the concentration is 33.9 percent in the ratio of 26.88:10, wherein the concentration of the separation liquid is 1.073+/-0.01g/L. A two-step method for separating umbilical cord blood mesenchymal stem cells comprises the following steps of: 1, precipitating red cells by a hydroxyethyl starch; and 2, separating the mesenchymal stem cells by the separation liquid of which the concentration is1.073g/L. The mesenchymal stem cell with the highest proportion in umbilical cord blood can be obtained by the separation liquid and the separation flow, the proportions of lymphocytes and mononuclear cells are very low, and the obtained cells are good in state and high in activity. The used materials and reagents are medical products, are non-toxic, do not have heat sources, can be industrially produced and are convenient to store. The used method is an optimized flow, is high in stability and repeatability, can be also used for separating human marrow and peripheral blood mesenchymal stem cells, is the best method for separating and extracting the mesenchymal stem cells in the current density gradient centrifugation and is better than other products and methods.
Owner:刘爱兵 +1

Method for measuring pollen density by improved density gradient centrifugation method

The invention discloses a method for measuring the pollen density by an improved density gradient centrifugation method. The method comprises the following steps of: dissolving cane sugar into water, preparing gradient solutions with different concentrations by mass percentage, mixing pollen to be measured into 10 percent crane sugar solution, and injecting the solution into the bottom of a centrifugation pipe; and then preparing a 20-70% crane sugar density gradient centrifugation solution by a layering method, centrifugating at the speed of 4,000 to 10,000rpm for 5 to 15 min, after the pollen reaches settlement balance, keeping the pollen still, taking crane sugar solution with concentration corresponding to the layer wherein the pollen is suspended, drawing an absorbance standard curve of the pollen to be measured in the crane sugar solution with the corresponding concentration, measuring an absorbance value of the crane sugar solution at the layer an which the pollen is suspended by taking the curve as a reference through a spectrophotometer under a wavelength of 290nm, and calculating the pollen density according to the formula shown in the specification. The method is suitable for measurement of various pollen densities; a result is accurate; the repetitiveness is high; the method is easy to operate and is feasible; and the number of demanded samples is small.
Owner:YUNNAN ACAD OF TOBACCO AGRI SCI +1

Separated culture method for primary hepatocyte of megalobrama amblycephala

The invention discloses a separated culture method for primary hepatocyte of megalobrama amblycephala. The method comprises the following steps: selecting healthy megalobrama amblycephala, the weightof which is 30-50 g; fully disinfecting the megalobrama amblycephala with 1% potassium hypermanganate; sampling blood from a caudal vein; carrying out sterile dissection to take liver; digesting the liver with collagenase and filtering the liver with a 200-mesh cell screen to obtain a cell suspension; removing residual erythrocytes in liver cells by an erythrocuyte lysate; then carrying out gradient centrifugation to remove cell fragments; adding a proper amount of full culture medium suspension cells into the obtained cell precipitate; then calculating and adjusting the cell concentration with a cell counter; after paving a board, putting the board in a 5% CO2 cell incubator to be cultured at 28 DEG C; observing the adherence condition within 48 hours. The method provided by the inventionseparates and cultures liver cells by combining the characteristics of a researched species creatively, and the survival rate of the obtained cells reaches 90% or higher which meets the primary culture demand, thereby providing a theoretical foundation and a technical support for further carrying out related experiments of primary hepatocyte of megalobrama amblycephala.
Owner:NANJING AGRICULTURAL UNIVERSITY

Nucleus pulposus-cartilage extracellular matrix scaffold and preparing method thereof

InactiveCN105031734AOvercome the disadvantages of small quantities and difficult accessGood biocompatibilityProsthesisArticular surfacesArticular surface
The invention discloses a nucleus pulposus-cartilage extracellular matrix scaffold and a preparing method thereof and belongs to the biological tissue engineering technology. The preparing method comprises the steps that nucleus pulposuses and bony articular surface cartilage are smashed, decellularized, subjected to gradient centrifugation to collect extracellular matrix microfilament suspension, and freeze-dried to obtain a freeze-dried decellularized nucleus pulposus matrix and a freeze-dried decellularized cartilage matrix, the two matrixes are taken in certain proportion and dissolved in ultrapure water to prepare mixed matrix suspension with certain concentration, and the mixed matrix suspension is freeze-dried and subjected to ultraviolet irradiation crosslinking and chemical reagent crosslinking in sequence so that the nucleus pulposus-cartilage extracellular matrix scaffold can be obtained. In this way, the defect that the nucleus pulposuses are hard to obtain due to the small number is overcome; the preparing technology is simple, and decellularizing can be achieved thoroughly; the matrix scaffold is degradable and high in biocompatibility; the matrix scaffold is of a three-dimensional structure, is high in mechanical property and plasticity, and can facilitate the distribution, growth and differentiation of seed cells; the freeze-dried extracellular matrixes are convenient to store and prepare and can be used for constructing a tissue engineered intervertebral disc to repair partial defects of the intervertebral disc, and broad clinical application prospects are realized.
Owner:TIANJIN HOSPITAL

Separation method of autotrophic bacteria and heterotrophic bacteria in activated sludge of sewage treatment plant

The invention provides a separation method of autotrophic bacteria and heterotrophic bacteria in activated sludge of a sewage treatment plant, which belongs to the technical field of biological sewage treatment. According to the method, DNAs of the autotrophic bacteria and the heterotrophic bacteria with different demands for types of carbon sources in the activated sludge of the sewage treatment plant can be separated, and the characteristics of the two types of bacteria can be analyzed at a gene level. The activated sludge of the sewage treatment plant is cultivated in situ by adopting 13C-marked inorganic matters or organic matters as carbon sources, and DNA solutions at different levels are obtained by adopting a superspeed density gradient centrifugation method of cesium chloride with high stability and good separation effect. The densities of the solutions at all levels after separation are cut down from big to small correspondingly in the bottom-to-top direction of a centrifugal tube. The characteristics of microbial communities of DNA samples at 5-9 levels are analyzed by adopting a real-time quantitative PCR (polymerase chain reaction) technology and a high throughput sequencing technology. The invention provides the economic, simple, convenient and reliable separation method of the autotrophic bacteria and the heterotrophic bacteria in the activated sludge of the sewage treatment plant.
Owner:BEIJING UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products